Schmitt, F.; Nguyen, S.; Claßen, P.C.; Meineck, M.; Hagen, M.; Weinmann-Menke, J.; Schmidlin, T.
Disease and Medication Context Shape Ex Vivo Metabolite Stability: A Pilot Study in Systemic Lupus Erythematosus. Metabolites 2025, 15, 738.
https://doi.org/10.3390/metabo15110738
AMA Style
Schmitt F, Nguyen S, Claßen PC, Meineck M, Hagen M, Weinmann-Menke J, Schmidlin T.
Disease and Medication Context Shape Ex Vivo Metabolite Stability: A Pilot Study in Systemic Lupus Erythematosus. Metabolites. 2025; 15(11):738.
https://doi.org/10.3390/metabo15110738
Chicago/Turabian Style
Schmitt, Fabian, Susanne Nguyen, Paul Christoph Claßen, Myriam Meineck, Mathias Hagen, Julia Weinmann-Menke, and Thierry Schmidlin.
2025. "Disease and Medication Context Shape Ex Vivo Metabolite Stability: A Pilot Study in Systemic Lupus Erythematosus" Metabolites 15, no. 11: 738.
https://doi.org/10.3390/metabo15110738
APA Style
Schmitt, F., Nguyen, S., Claßen, P. C., Meineck, M., Hagen, M., Weinmann-Menke, J., & Schmidlin, T.
(2025). Disease and Medication Context Shape Ex Vivo Metabolite Stability: A Pilot Study in Systemic Lupus Erythematosus. Metabolites, 15(11), 738.
https://doi.org/10.3390/metabo15110738